Concepedia

Malaka Ameratunga

MA

16

Publications

696

Citations

14

H-Index

2016

Active since

Affiliations

The University of Melbourne(Current)

Austin Health

Olivia Newton-John Cancer Wellness & Research Centre

La Trobe University

Institute of Cancer Research

Malaka Ameratunga is an author at The University of Melbourne specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2016–2023

16

Publications

16

The kinase polypharmacology landscape of clinical PARP inhibitors

Albert A. Antolín, Malaka Ameratunga, Udai Banerji et al. · Scientific Reports · 2020 · 114 citations · Full text

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma

Bibhusal Thapa, Adriana Salcedo, Xihui Lin et al. · Journal of Thoracic Oncology · 2017 · 96 citations · Full text

, , +6

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

Malaka Ameratunga, Irene Braña, Petri Bono et al. · British Journal of Cancer · 2020 · 86 citations · Full text

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC

Malaka Ameratunga, Khashayar Asadi, Xihui Lin et al. · PLoS ONE · 2016 · 81 citations · Full text

Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors

Malaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo et al. · European Journal of Cancer · 2017 · 75 citations

, , +8

Rows per page

1–5 of 16